Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5‐hydroxytryptamine and noradrenaline release in the rat neocortex
Matteo Marti(University of Ferrara), Michele Morari(University of Padua), Timothy Barnes(Johns Hopkins University), Girolamo Calò(University of Padua), David G. Lambert(Griffith University), F Mela(University of Ferrara), Remo Guerrini(University of Ferrara), Carmela De Risi(University of Ferrara), Clementina Bianchi, Sara Stocchi(University of Ferrara), Lorenzo Beani(University of Ferrara), Francesca Paganini(University of Ferrara)
Cited by 62
Related Papers
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
|Nature Genetics|2011|2k
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
|Progress in Neurobiology|2015|472
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432